SCHEMBL18655420

SCHEMBL18655420

CC(C)c1ncnn1CC(C)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11967288 0.87 ADRA1A (0.32) —
SCHEMBL24768960 0.77 TLR9 (0.31) —
SCHEMBL12410848 0.75 XDH (0.32) —
SCHEMBL24768980 0.74 ACVRL1 (0.30) —
SCHEMBL24768869 0.73 — —
SCHEMBL19219033 0.72 ADORA2A (0.32) —
SCHEMBL24769770 0.69 MAPT (0.38) —
SCHEMBL12410719 0.69 — —
SCHEMBL30281146 0.68 PIK3CA (0.33) —
SCHEMBL2737316 0.68 MAPK1 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170081341-A1 BENZOXAZEPIN PI3K INHIBITOR COMPOUNDS AND METHODS OF USE GENENTECH, INC. (US) 2017-03-23 — — US disclosed
Send feedback